196 related articles for article (PubMed ID: 10640587)
1. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
Law SL; Huang KJ; Chiang CH
J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
[TBL] [Abstract][Full Text] [Related]
2. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
3. Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir.
Fresta M; Panico AM; Bucolo C; Giannavola C; Puglisi G
J Pharm Pharmacol; 1999 May; 51(5):565-76. PubMed ID: 10411216
[TBL] [Abstract][Full Text] [Related]
4. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
5. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery.
Mohammadi M; Elahimehr Z; Mahboobian MM
Curr Eye Res; 2021 Nov; 46(11):1646-1652. PubMed ID: 33979552
[No Abstract] [Full Text] [Related]
7. Intraocular penetration of topically administered acyclovir.
Kitagawa K; Fukuda M; Sasaki K
Lens Eye Toxic Res; 1989; 6(1-2):365-73. PubMed ID: 2488028
[TBL] [Abstract][Full Text] [Related]
8. Liposomes as a potential ocular delivery system of distamycin A.
Chetoni P; Monti D; Tampucci S; Matteoli B; Ceccherini-Nelli L; Subissi A; Burgalassi S
Int J Pharm; 2015 Aug; 492(1-2):120-6. PubMed ID: 26183332
[TBL] [Abstract][Full Text] [Related]
9. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
Liu H; Pan WS; Tang R; Luo SD
Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
[TBL] [Abstract][Full Text] [Related]
10. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir.
Seyfoddin A; Sherwin T; Patel DV; McGhee CN; Rupenthal ID; Taylor JA; Al-Kassas R
Curr Drug Deliv; 2016; 13(6):923-34. PubMed ID: 26568139
[TBL] [Abstract][Full Text] [Related]
12. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
13. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
Hughes PM; Mitra AK
J Ocul Pharmacol; 1993; 9(4):299-309. PubMed ID: 8106836
[TBL] [Abstract][Full Text] [Related]
14. [Intraocular penetration of acyclovir after topical and systemic administration].
Kitagawa K; Fukuda M; Chou JS; Sasaki K
Nippon Ganka Gakkai Zasshi; 1987 Dec; 91(12):1160-3. PubMed ID: 3448900
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
16. Bioadhesive microspheres for ophthalmic administration of acyclovir.
Genta I; Conti B; Perugini P; Pavanetto F; Spadaro A; Puglisi G
J Pharm Pharmacol; 1997 Aug; 49(8):737-42. PubMed ID: 9379347
[TBL] [Abstract][Full Text] [Related]
17. Enhancer effects on in vitro corneal permeation of timolol and acyclovir.
Montenegro L; Bucolo C; Puglisi G
Pharmazie; 2003 Jul; 58(7):497-501. PubMed ID: 12889536
[TBL] [Abstract][Full Text] [Related]
18. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
19. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line.
Tak RV; Pal D; Gao H; Dey S; Mitra AK
J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
Alsarra IA; Hamed AY; Alanazi FK
Drug Deliv; 2008 Jun; 15(5):313-21. PubMed ID: 18763162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
